Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518610 | SCV000613847 | benign | not specified | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000766997 | SCV000619987 | likely benign | not provided | 2020-03-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24440382) |
Labcorp Genetics |
RCV001078864 | SCV000640058 | benign | Spinocerebellar ataxia type 19/22 | 2023-05-25 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852587 | SCV000995289 | benign | Primary dilated cardiomyopathy | 2019-06-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002383993 | SCV002693125 | likely benign | Cardiovascular phenotype | 2021-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004553134 | SCV004790200 | likely benign | KCND3-related disorder | 2019-04-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV000766997 | SCV005259281 | likely benign | not provided | criteria provided, single submitter | not provided |